Targeting the Fanconi Anemia Pathway to Identify Tailored Anticancer Therapeutics

Chelsea Jenkins, Jenny Kan, Maureen E. Hoatlin

Open source

DOI
10.1155/2012/481583
Published
2012
Container
Anemia
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2012/481583,
  title = {Targeting the Fanconi Anemia Pathway to Identify Tailored Anticancer Therapeutics},
  author = {Chelsea Jenkins and Jenny Kan and Maureen E. Hoatlin},
  year = {2012},
  journal = {Anemia},
  doi = {10.1155/2012/481583},
  url = {https://doi.org/10.1155/2012/481583}
}

RIS

TY  - JOUR
TI  - Targeting the Fanconi Anemia Pathway to Identify Tailored Anticancer Therapeutics
AU  - Chelsea Jenkins
AU  - Jenny Kan
AU  - Maureen E. Hoatlin
PY  - 2012
JO  - Anemia
DO  - 10.1155/2012/481583
UR  - https://doi.org/10.1155/2012/481583
ER  - 

APA

Jenkins, C., Kan, J., & Hoatlin, M. E. (2012). Targeting the Fanconi Anemia Pathway to Identify Tailored Anticancer Therapeutics. Anemia. https://doi.org/10.1155/2012/481583

Source records